SOURCE: SpectraScience, Inc.
DUBAI, UNITED ARAB EMIRATES--(Marketwire - Jan 30, 2013) - SpectraScience, Inc. (OTCQB: SCIE), a San Diego based medical device company, today announced that in continuation of its distribution and sales efforts in Europe and the Middle East it is demonstrating its WavSTAT4 Optical Biopsy System at the 38th Annual Arab Health 2013 Exhibition and Congress. The Exhibition is taking place January 28th through 31st, 2013 in Dubai, United Arab Emirates. The WavSTAT4 Optical Biopsy System is available for demonstration at the PENTAX Europe booth at the Exhibition.
"Arab Health is a great venue for meeting and educating customers in the Middle East, North Africa and South Asia, important developing markets for the WavSTAT4 System," said Mike Oliver, President and CEO of SpectraScience. "The WavSTAT4 can be an attractive cost-saving diagnostic when used in colorectal screening programs in these markets."
About SpectraScience, Inc.
SpectraScience is a San Diego based medical device company that designs, develops, manufactures and markets light-based analysis systems capable of determining whether tissue is normal, pre-cancerous or cancerous without physically removing tissue from the body. The WavSTAT4 Optical Biopsy System uses light to optically diagnose tissue and provide the physician with an immediate result. With approval for sale under the CE Mark for the European Union and other international markets, the WavSTAT4 System is the first commercially available product that incorporates this innovative technology for clinical use.
About Arab Health
Arab Health, now in its 38th year, is the world's longest running healthcare Exhibition and Congress, taking place every January in Dubai. With the Middle East healthcare industry worth an estimated $80 billion annually, Arab Health presents an important opportunity for healthcare providers. For more information, visit www.arabhealthonline.com.